** Shares of WuXi Biologics (Cayman) Inc 2269.HK jump 4.9% to HK$30.15, their highest since January 2024, and on course for a third consecutive session of gains
** Stock set for the biggest one-day pct gain since June 9, if current gains hold
** Co expects H1 revenue to increase 16% y/y, profit attributable to equity shareholders to rise 56% and gross profit margin to expand 3.6%
** The Hang Seng Biotech Index .HSHKBIO rises 1.1%, the benchmark Hang Seng Index .HSI adds 0.7%
** YTD, stock up 70.6%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。